semaglutide deaths 2024 flow trial renal outcomes 🚨 Journal Club: Review 🚨 The FLOW Trial, published in Sudden Death in Obesity: Mechanisms

Thank you for telling us about your experience

This includes baseline labs, follow-up testing, vital sign monitoring, and dose adjustments based on the patients individual response

As lifestyle-related diseases surge due to sedentary behavior, poor diet, and aging populations, the demand for effective treatments like GLP-1 agonists grows

With GLP-1 medications, this may happen due to delayed gastric emptying, which allows food to remain in the stomach longer, potentially leading to bacterial fermentation and gas production with a characteristic sulphurous odour

Statistical significance was determined by multiple two-tailed unpaired t-tests